Today

We have more than 30 years of experience within laryngectomy care, subsidiaries in 19 countries, and over 750 Atos employees  worldwide.

Atos Medical is owned by PAI Partners, one of the leading private equity companies in Europe, together with Atos’ board of directors and management team.

2015

To be closer to our consumers and markets, Atos opened a new headquarter office in Malmö. Our R&D center and manufacturing site remains in Hörby.

2014

Determined to give more people the freedom to speak hands-free, we launched Provox FreeHands FlexiVoice, which can be used with our most advanced adhesive Provox StabiliBase.

2013

Further international expansion took place outside of Europe by establishing subsidiaries in Japan and Brasil in 2013, in the south of Europe with a subsidiary in Italy, and expansion into several countries in the Nordics.

2012

To meet growing demand, we expanded our R&D and manufacturing site in Hörby, which now houses injection molding, assembly, a tool shop, quality control, packaging, warehousing and over 150 of our employees.

2011

In order to support and accelerate Atos’ growth-oriented strategy, EQT acquires Atos Medical from Nordic Capital.

2010

We introduced our second generation of Provox HMEs: the Provox XtraFlow and Provox XtraMoist HMEs.  These HMEs have excellent humidification and airflow performance characteristics  and set the standard in the industry.

2004

During 2004 and 2005 rapid international expansion occurred by establishing subsidiaries in the Netherlands, Spain, Switzerland, and Belgium followed by Portugal in 2008 and France in 2010.

2003

Designed for patients with early leakage, we introduced Provox ActiValve, our most advanced voice prosthesis, containing magnets that prevent inadvertent opening.

2000

Further international expansion took place by establishing a subsidiary in the United States, followed by Germany in 2002.

1997

The second generation Provox voice prosthesis, Provox®2, was launched. Over the years, this would be followed by a third generation, as well as several specialty Provox voice prostheses.

1996

In 1996 we began our international expansion by establishing our first subsidiary in the UK.

1995

The first Provox HME was launched, together with a range of Provox adhesives.

1990

The first Provox® voice prosthesis was launched and turned out to be an instant success. Already in its first year, its use spread throughout Europe.

1987

In 1987, Atos Medical initiated a collaboration with Professor Frans Hilgers and his colleagues at the Netherlands’ Cancer institute. Using the Netherland’s Cancer Institute’s medical expertise, Atos Medical’s capabilities within silicone injection molding in the medical technology industry, the development of an indwelling voice prosthesis with low airflow resistance for easy speaking began.

1986

Atos Medical was founded in the south of Sweden by the brothers Gert and Jan-Ove Persson. Today, we still have our world-class research and development center and state-of-the-art cleanroom and manufacturing site in Hörby, Sweden.

The Board of Directors include:

• Lars Frederiksen (Chairman)
• Ragnar Hellenius (Vice chairman of the Board)
• Frédéric Stévenin
• Carl Settergren
• Andreas Kumeth
• Claus Bjerre
• Göran Jönsson (Union representative)
• Karin Johansson (Union representative)

The Management Team includes:

• Britt Meelby Jensen (Chief Executive Officer)
• Philip Eickhoff (Chief Financial Officer)
• Ulrik Berthelsen (Senior Vice President, Northern & Southern Europe, Japan, and Emerging Markets)
• Mark Reade (Senior Vice President, North America)
• Michael Jakobi (Senior Vice President, Germany, Switzerland, and Austria)
• Jens Mondrup (Senior Vice President, Innovation & Marketing)
• Dorthe Rønnau (Senior Vice President, Human Resources)
• Christian Skak Olufsen (Vice President, General Counsel, Legal Affairs and Compliance)
• Martin Richardson (Senior Vice President, Operations)